Every share has an antogonist on hc. M.O. is always very similar. Makes it feel like cynical exercise to make people comment and visit.
Anyways- sales force take time to spool up and there's a decent number there now and possibly with the entrenched ceo, maybe getting on board faster and revenue generating sooner.
Board is very keen to have this coverage as they know front and regular centre to client translates to sales.
TAM has also grown as seen in the clinician's speak thread.
Class leader product, sales team, KOL's and ready availability of products can only mean that sales trajectory will be maintained off of a bigger sales base.
The board believes each mature sales person is good for 1m and I can't wait for the sales update, when and if it comes.
price of share is just a product of relativity to gross sales at the moment. I think sales growth will eventually win over and get momentum back into the sp.
until then it's a chew toy for shorters.
The Clinicians Speak, page-653
-
- There are more pages in this discussion • 369 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.59 |
Change
0.220(9.28%) |
Mkt cap ! $1.787B | |||
| Open | High | Low | Value | Volume |
| $2.44 | $2.62 | $2.44 | $11.81M | 4.632M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 8020 | $2.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.59 | 48292 | 7 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |